|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
and Its Soluble Receptor Forms, and Interleukin-1ß and Interleukin-1 Receptor Antagonist in BAL Fluid of Cavitary Pulmonary Tuberculosis*
* From the Division of Pulmonary and Critical Care Medicine (Drs. Tsao, Hong, Li, and Hsieh), Chang Gung Memorial Hospital, Taipei, and the Graduate Institute of Clinical Medicine (Drs. Liao and Chang), Chang Gung University, Linko, Taiwan.
Correspondence to: Thomas C.Y. Tsao, MD, Division of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, 199 Tun-Hwa North Rd, Taipei, Taiwan; e-mail: drtsao{at}adm.cgmh.com.tw
Objectives: We investigated the possibility that the
large pulmonary cavity in tuberculosis (TB) lesions might result from
imbalances between tumor necrosis factor-
(TNF-
) and soluble
TNF-
receptor forms (sTNF-RI and sTNF-RII), and interleukin-ß
(IL-1ß) and IL-1 receptor antagonist (IL-1RA) in sites of local
inflammation.
Patients and methods: BAL was performed
in 32 patients with active pulmonary TB, and the recovered BAL fluid
(BALF) was examined for concentrations of TNF-
and its soluble
receptor forms, IL-1ß, and IL-1RA. Patients were classified into two
groups: group 1, patients with a large cavity (
4 cm) on chest
radiographs (n = 15); and group 2, patients with a small cavity
(< 4 cm; n = 3) or no cavity (n = 14) on chest radiographs.
Results: The concentrations of TNF-
, IL-1ß, and IL-1RA
in BALF were significantly higher in group 1 patients than in group 2
patients before standardization. The difference was also statistically
significant for TNF-
and IL-1ß after standardization with urea.
Furthermore, group 1 patients had significantly higher ratios of
TNF-
to sTNF-RI and sTNF-RII and IL-1ß to IL-1RA compared with
group 2 patients.
Conclusions: These findings suggest
that the relative abundance of TNF-
and IL-1ß associated with
imbalances of secretion of soluble TNF-
receptor forms and IL-1RA
may have caused tissue necrosis leading to cavity formation in patients
with active pulmonary TB.
Key Words: interleukin-1ß interleukin-1 receptor antagonist pulmonary tuberculosis soluble tumor necrosis factor-
receptor forms tumor necrosis factor-
This article has been cited by other articles:
![]() |
C. A. Buckley, F. N. Rouhani, M. Kaler, B. Adamik, F. I. Hawari, and S. J. Levine Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1132 - L1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Douillet, W. P. Robinson III, B. L. Zarzaur, E. R. Lazarowski, R. C. Boucher, and P. B. Rich Mechanical Ventilation Alters Airway Nucleotides and Purinoceptors in Lung and Extrapulmonary Organs Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 52 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Florido and R. Appelberg Granuloma Necrosis during Mycobacterium avium Infection Does Not Require Tumor Necrosis Factor Infect. Immun., October 1, 2004; 72(10): 6139 - 6141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rupp, H. Kothe, A. Mueller, M. Maass, and K. Dalhoff Imbalanced secretion of IL-1{beta} and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients Eur. Respir. J., August 1, 2003; 22(2): 274 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Y. Tsao, C.-H. Chen, J.-h. Hong, M.-J. Hsieh, K.-C. Tsao, and C.-H. Lee Shifts of T4/T8 T Lymphocytes From BAL Fluid and Peripheral Blood by Clinical Grade in Patients With Pulmonary Tuberculosis Chest, October 1, 2002; 122(4): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ebong, S. M. Goyert, J. A. Nemzek, J. Kim, G. L. Bolgos, and D. G. Remick Critical Role of CD14 for Production of Proinflammatory Cytokines and Cytokine Inhibitors during Sepsis with Failure To Alter Morbidity or Mortality Infect. Immun., April 1, 2001; 69(4): 2099 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Mohamed, A. A. M. T. Mobasher, A.-R. I. Yousef, A. Salah, I. Z. El-Naggar, A. H. A. Ghoneim, and R. W. Light BAL Neopterin : A Novel Marker for Cell-Mediated Immunity in Patients With Pulmonary Tuberculosis and Lung Cancer Chest, March 1, 2001; 119(3): 776 - 780. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |